Bisfosfonatassocieret osteonekrose i kaeberne hos patienter med myelomatose

Thomas Lund, Henrik Gregersen, Annette Vangsted, Peter Marker, Niels Abildgaard

    5 Citationer (Scopus)

    Abstract

    Bisphosphonate-associated osteonecrosis of the jaw (BON) is mainly observed in patients with multiple myeloma, and to a lesser extent in breast and prostate cancer patients receiving intravenous treatment with potent bisphosphonates. The incidence of BON increases with the duration of bisphosphonate therapy and with the potency of the used bisphosphonate. BON usually develops after tooth extraction or other oral surgery, and has proven difficult to treat. Optimal dental hygiene should be ensured prior to treatment initiation where possible, and once bisphosphonate treatment is instituted, oral surgery should be avoided if possible.
    Udgivelsesdato: 2009-Jan
    Bidragets oversatte titelBisphosphonate-associated osteonecrosis of the jaw in patients with multiple myeloma
    OriginalsprogDansk
    TidsskriftUgeskrift for læger
    Vol/bind171
    Udgave nummer1-2
    Sider (fra-til)50-2
    Antal sider3
    ISSN0041-5782
    StatusUdgivet - 2009

    Citationsformater